Oric Pharma grants 161,550 inducement stock options to new hires under 2022 plan

By Public Technologies
  • Oric Pharmaceuticals granted 161,550 non-qualified stock options, 26,850 restricted stock units to six new non-executive hires.
  • Grants were issued Oct. 1, 2026 under the 2022 Inducement Equity Incentive Plan.
  • Options carry an exercise price set at the stock’s closing price on the grant date.
  • Option vesting: 25% after one year, remaining balance monthly over 36 months.
  • RSU vesting: one-third on each of the first three anniversaries of the grant date.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oric Pharmaceuticals Inc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610021630PRIMZONEFULLFEED9838325) on October 02, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk